Comparison between thoracic ultrasound and chest x-ray in detection of non-infective early complications of cardiac implantable electronic devices implantation (CRUSADERS study) [0.03%]
心脏植入式电子设备植入术后非感染早期并发症的胸部超声和胸片对比研究(CRUSADERS研究)
Roberto Floris,Gabriele Dell&#x;Era,Lorenzo Pimpini et al.
Roberto Floris et al.
Background and aims: Chest radiography (CXR) is the gold standard tool for early mechanical complications' detection after cardiac implantable electronic devices (CIED) procedures, along with CIED electrical parameters co...
Hun Jee Choe,Talal Almas,Ian J Neeland et al.
Hun Jee Choe et al.
Background: Obesity and atherogenic dyslipidemias are interrelated disorders that substantially contribute to the development of atherosclerotic cardiovascular disease (ASCVD) and the broader cardiovascular-kidney-metabol...
Alberto M Borobia,Juliette Guillot,Amanda Bok et al.
Alberto M Borobia et al.
The conservativeness of standard C statistics in the prediction of clinical events [0.03%]
标准循环内皮活化标志物预测心血管事件的保守性分析
Carmine Zoccali,Giovanni Tripepi
Carmine Zoccali
The C statistic, also known as the concordance index (C-index), is widely used in clinical research to assess the discriminative ability of risk prediction models. Its appeal lies in its intuitive interpretation and broad applicability, par...
Assessing the interaction of the UCP system and fatty acids on epicardial adipose tissue mitochondrial respiration [0.03%]
评估UCP系统与脂肪酸对心外膜脂肪组织线粒体呼吸相互作用的影响
Diana Santos,Ana Burgeiro,Ana Catarina R G Fonseca et al.
Diana Santos et al.
Background: Epicardial adipose tissue (EAT) exhibits brown-like features, including the expression of uncoupling protein 1 (UCP1). EAT interacts dynamically with cardiac cells to modulate local cardiac tissue physiology a...
Integrated biomarker landscape for the early detection and management of calcific aortic valve disease [0.03%]
降钙素基因相关肽治疗对慢性心力衰竭患者血浆神经激素的影响研究——附36例临床分析
Alberto Cook-Calvete,Silvia Moreta,Maria Delgado-Marin et al.
Alberto Cook-Calvete et al.
Background: Calcific aortic valve disease (CAVD) is the predominant valvular pathology in older adults, advancing from aortic sclerosis to life-threatening stenosis. Without effective medical therapies, intervention mainl...
Effectiveness of direct oral anticoagulants for all-cause mortality and cardiovascular events in overweight and obese patients with atrial fibrillation: Insight from the nationwide START registry [0.03%]
来自全国START登记处的肥胖和超重房颤患者使用直接口服抗凝剂对全因死亡率及心血管事件的影响效果分析
Danilo Menichelli,Gianluca Gazzaniga,Emilia Antonucci et al.
Danilo Menichelli et al.
Background: Overweight and obesity are highly prevalent in atrial fibrillation (AF) patients, yet the best anticoagulant strategy for this group is still unclear. We evaluated the risk of all-cause mortality and cardiovas...
Comprehensive venous outflow is the optimal venous score in predicting functional outcome in acute ischemic stroke patients [0.03%]
全面静脉引流是急性缺血性卒中患者预后功能的最优预测静脉评分
Giorgio Busto,Andrea Morotti,Ilaria Casetta et al.
Giorgio Busto et al.
Background: Venous outflow (VO) is a promising prognostic imaging biomarker in acute ischemic stroke (AIS) patients selected for endovascular treatment (EVT). However, the best score for properly assessing VO profiles on ...
Global, regional and national burden of epilepsy in children and adolescents, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021 [0.03%]
1990年至2021年全球、区域和国家癫痫疾病负担（1990-2021年全球疾病负担研究系统分析）
Yun Seo Kim,Min Seo Kim,Seoyeon Park et al.
Yun Seo Kim et al.
Background: Epilepsy is a common neurological disease that heavily impacts children and adolescents and carries serious physical, cognitive, psychological, social and economic consequences for patients and their caregiver...
Long-term effectiveness and safety outcomes in adults with Fabry disease treated with agalsidase alfa: 20 years of data from the Fabry Outcome Survey [0.03%]
α-半乳糖苷酶A替代疗法治疗法布雷病成人患者长期有效性和安全性的临床观察：长达20年的法布雷数据库研究结果
Derralynn A Hughes,Guillem Pintos-Morell,Christoph Kampmann et al.
Derralynn A Hughes et al.
Background: We present the final report from the Fabry Outcome Survey (FOS) on long-term effectiveness and safety of agalsidase alfa in adults (≥18 years old). ...